210 related articles for article (PubMed ID: 17063495)
21. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?
Liman AK; Giampoli EJ; Bonfiglio TA
Cancer; 2005 Dec; 105(6):457-60. PubMed ID: 16104044
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
23. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
24. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
25. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
26. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
[TBL] [Abstract][Full Text] [Related]
27. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
29. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
30. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
31. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
[TBL] [Abstract][Full Text] [Related]
32. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.
Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK
Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848
[TBL] [Abstract][Full Text] [Related]
33. p16 is superior to ProEx C in identifying high-grade squamous intraepithelial lesions (HSIL) of the anal canal.
Bala R; Pinsky BA; Beck AH; Kong CS; Welton ML; Longacre TA
Am J Surg Pathol; 2013 May; 37(5):659-68. PubMed ID: 23552383
[TBL] [Abstract][Full Text] [Related]
34. Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
Ma YY; Cheng XD; Zhou CY; Qiu LQ; Chen XD; Lü WG; Xie X
Chin Med J (Engl); 2011 Aug; 124(16):2443-7. PubMed ID: 21933584
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
Bergeron C; Ikenberg H; Sideri M; Denton K; Bogers J; Schmidt D; Alameda F; Keller T; Rehm S; Ridder R;
Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of HPV L1 capsid protein detection in cervical exfoliated cells in high-risk HPV positive women].
Wang J; Tian Q; Zhang S; Lyu L; Dong J; Lyu W
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):253-7. PubMed ID: 26080935
[TBL] [Abstract][Full Text] [Related]
37. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
38. Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis.
Wei Q; Fu B; Liu J; Xu J; Zhao T
Int J Clin Exp Pathol; 2013; 6(8):1549-57. PubMed ID: 23923073
[TBL] [Abstract][Full Text] [Related]
39. mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer.
Del Pino M; Svanholm-Barrie C; Torné A; Marimon L; Gaber J; Sagasta A; Persing DH; Ordi J
Mod Pathol; 2015 Feb; 28(2):312-20. PubMed ID: 25189639
[TBL] [Abstract][Full Text] [Related]
40. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
Wentzensen N; Schwartz L; Zuna RE; Smith K; Mathews C; Gold MA; Allen RA; Zhang R; Dunn ST; Walker JL; Schiffman M
Clin Cancer Res; 2012 Aug; 18(15):4154-62. PubMed ID: 22675168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
